Antonio Lopez-Beltran is currently Director of the Anatomic Pathology Service for Champalimaud Clinical Center in Lisbon, Portugal. Prior to this role, he was Director of Anatomic Pathology for Althia Health in Barcelona and Full Professor of Anatomic Pathology at the University of Cordoba. Before this, he spent 27 years at the University of Cordoba, Spain where he created and was Director of the Uro-Oncology Research Lab. During this time, Professor Lopez- Beltran designed and implemented novel molecular techniques to evaluate prognostic features of bladder and prostate cancer and, over the years, the team discovered and/or validated some biomarkers of clinical utility, mostly tissue and urine related. Studies from the Uro-Oncology Research Lab enabled Professor Lopez-Beltran to be a ‘Highly Cited Author’ by the Institute of Scientific Information with an h-index of 61.
Professor Lopez-Beltran received his medical degree at the University of Seville, Spain, in 1979, then completed the residency programme in Anatomic Pathology until 1982 and received a PhD in Experimental Pathology at the University of Cordoba in 1984. He was also visiting physician pathologist at the pathology service of the University College (London, UK, 1986; 6 months), Roswell Park Cancer Institute (Buffalo, NY, 1987–1989) and Mayo Clinic (Rochester, MN, 1995; 6 months). He is a member of several international pathological organisations and the current Chair of the European Working Group on Urologic Pathology of the European Society of Pathology.
EM-06830 - Date of preparation: March 2019